跳至主要内容
临床试验/CTRI/2023/11/059621
CTRI/2023/11/059621尚未招募2 期

An open label, non randomized, interventional study to evaluate the efficacy and safety of microneedling combined with 5-fluorouracil 5% cream versus microneedling combined with tacrolimus 0.1% ointment versus microneedling alone in clinically stable vitiligo patients - NI

Dr Sushnitha Johnson0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All patients aged from 18 to 50 years with localized & stable vitiligo for a year willing to come for regular follow up. 2.No history of topical application for 2 weeks, oral medication for 4 weeks, phototherapy and excimer laser for 8 weeks when enrolled in the study. 3.Patients with 3 or more stable vitiligo patches

排除标准

  • 1.Pregnant or lactating women
  • 2.Presence of Bleeding /coagulation disorders
  • 3.Past history of keloidal tendency
  • 4.Patients with active infections
  • 5.Patients with known allergy to 5-fluorouracil, tacrolimus
  • 6.Immunosuppressed patients
  • 7.Any concomitant skin conditions over the vitiligo patch
  • 8.Mucosal and palmoplantar vitiligo

研究者

发起方
Dr Sushnitha Johnson

相似试验